Nasdaq · CIK 0001832038
IVVD Invivyd, Inc.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $0.72 on Oct 9, 2026, +35% from the 52-week low and -75% from the high.
Invivyd, Inc. (IVVD) has 42 SEC Form 4 filings on file from 12 insiders, the latest filed on Sep 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
16 open-market trades have been scored at IVVD. The newest: Robert D. Allen III (Chief Scientific Officer) sold $59k of stock on Feb 17, 2026, filed Feb 18, 2026, scored 7 (weak), under a 10b5-1 plan. The largest of the 16 shown: Terrance McGuire (director) sold $289k on Dec 9, 2024, scored 34 (weak). 5 insiders sold within 14 days of each other around Feb 17, 2026.
IVVD closed at $0.72 on Oct 9, 2026, 35% above its 52-week low and 75% below its 52-week high.
11 Form 144 notices of planned sales are on file, the latest filed Feb 17, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Invivyd, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Robert D. Allen III Chief Scientific Officer sell | $59k 37,581 shares | -25% | +229% from low-46% from high | |
| 15Weak | Jill Andersen Chief Legal Officer, Secretary sell | $106k 67,710 shares | -27% | +229% from low-46% from high | |
| 20Weak | William E. Duke Chief Financial Officer sell | $63k 40,627 shares | -27% | +229% from low-46% from high | |
| 13Weak | Julie Green Chief Human Resources Officer sell | $63k 40,627 shares | -27% | +229% from low-46% from high | |
| 13Weak | Timothy Edward Lee Chief Commercial Officer sell | $63k 40,627 shares | -26% | +229% from low-46% from high | |
| 33Weak | Kevin F McLaughlin director buy | $125k 50,000 shares | - | +598% from low-12% from high | |
| 10Weak | Robert D. Allen III Chief Scientific Officer sell | $28k 45,932 shares | -46% | +62% from low-72% from high | |
| 12Weak | Jill Andersen Chief Legal Officer, Secretary sell | $50k 82,754 shares | -49% | +62% from low-72% from high | |
| 27Weak | William E. Duke Chief Financial Officer sell | $30k 49,656 shares | -50% | +62% from low-72% from high | |
| 20Weak | Julie Green Chief Human Resources Officer sell | $30k 49,656 shares | -50% | +62% from low-72% from high | |
| 10Weak | Timothy Edward Lee Chief Commercial Officer sell | $30k 49,656 shares | -46% | +62% from low-72% from high | |
| 26Weak | Terrance McGuire director sell | $132k 273,763 shares | -8% | - | |
| 26Weak | Terrance McGuire director sell | $165k 347,559 shares | -9% | - | |
| 26Weak | Terrance McGuire director sell | $148k 324,241 shares | -8% | - | |
| 25Weak | Terrance McGuire director sell | $103k 190,359 shares | -5% | - | |
| 34Weak | Terrance McGuire director sell | $289k 485,400 shares | -10% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | Allen Robert D. III Officer | 36,630 0.01% of outstanding | $57k | Feb 17, 2026 | none |
| Feb 17, 2026 | Andersen Jill Officer | 66,000 0.02% of outstanding | $103k | Feb 17, 2026 | none |
| Dec 23, 2025 | ADIMAB, LLC 10% Stockholder | 192,320 0.08% of outstanding | $577k | Dec 23, 2025 | $3.7M |
| Nov 17, 2025 | ADIMAB, LLC 10% Stockholder | 1,233,416 0.53% of outstanding | $3.7M | Nov 17, 2025 | none |
| Aug 18, 2025 | Allen Robert D. III Officer | 36,631 0.03% of outstanding | $26k | Aug 18, 2025 | none |
| Aug 18, 2025 | Andersen Jill Officer | 66,000 0.05% of outstanding | $47k | Aug 18, 2025 | none |
| Aug 18, 2025 | Duke William E. Officer | 39,601 0.03% of outstanding | $28k | Aug 18, 2025 | none |
| Aug 18, 2025 | Green Julie Officer | 39,600 0.03% of outstanding | $28k | Aug 18, 2025 | none |
| Aug 18, 2025 | Lee Timothy Edward Officer | 39,600 0.03% of outstanding | $28k | Aug 18, 2025 | none |
| Dec 20, 2024 | POLARIS PARTNERS IX, LP Director | 1,000,000 0.84% of outstanding | $444k | Dec 20, 2024 | $541k |
| Dec 9, 2024 | POLARIS PARTNERS IX, LP Director | 1,000,000 0.84% of outstanding | $610k | Dec 9, 2024 | none |
Transactions
The newest 50 of 87 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Ian Sheffield director | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | 41 d ago |
| Aug 30, 2026 | Marc Elia Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +10,700,000 | $0.00 | $0 | 10,700,000 | 42 d ago |
| May 19, 2026 | Ajay Royan director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 21, 2026 |
| May 19, 2026 | Paul Bolno director | AGrant or award Stock Option (Right to Buy)derivative | +32,876 | $0.00 | $0 | 32,876 | May 21, 2026 |
| May 19, 2026 | Kevin F McLaughlin director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 21, 2026 |
| May 19, 2026 | Marc Elia Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 21, 2026 |
| May 19, 2026 | Terrance McGuire director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 21, 2026 |
| May 19, 2026 | Tamsin Berry director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 21, 2026 |
| Feb 15, 2026 | Robert D. Allen III Chief Scientific Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 152,068 | Feb 18, 2026 |
| Feb 15, 2026 | Jill Andersen Chief Legal Officer, Secretary | MOption exercise Common Stock10b5-1 | +165,000 | - | - | 249,446 | Feb 18, 2026 |
| Feb 15, 2026 | Julie Green Chief Human Resources Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 148,344 | Feb 18, 2026 |
| Feb 15, 2026 | William E. Duke Chief Financial Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 148,344 | Feb 18, 2026 |
| Feb 15, 2026 | Timothy Edward Lee Chief Commercial Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 158,344 | Feb 18, 2026 |
| Feb 17, 2026 | William E. Duke Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -19,663 | $1.54 | $30k | 128,681 | Feb 18, 2026 |
| Feb 17, 2026 | Julie Green Chief Human Resources Officer | SOpen-market sale Common Stock10b5-1 | -19,663 | $1.54 | $30k | 128,681 | Feb 18, 2026 |
| Feb 17, 2026 | Timothy Edward Lee Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -19,663 | $1.54 | $30k | 138,681 | Feb 18, 2026 |
| Feb 17, 2026 | Robert D. Allen III Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -18,189 | $1.54 | $28k | 133,879 | Feb 18, 2026 |
| Feb 17, 2026 | Jill Andersen Chief Legal Officer, Secretary | SOpen-market sale Common Stock10b5-1 | -32,771 | $1.54 | $50k | 216,675 | Feb 18, 2026 |
| Feb 18, 2026 | Robert D. Allen III Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -19,392 | $1.58 | $31k | 114,487 | Feb 18, 2026 |
| Feb 18, 2026 | Jill Andersen Chief Legal Officer, Secretary | SOpen-market sale Common Stock10b5-1 | -34,939 | $1.58 | $55k | 181,736 | Feb 18, 2026 |
| Feb 18, 2026 | William E. Duke Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -20,964 | $1.58 | $33k | 107,717 | Feb 18, 2026 |
| Feb 18, 2026 | Julie Green Chief Human Resources Officer | SOpen-market sale Common Stock10b5-1 | -20,964 | $1.58 | $33k | 107,717 | Feb 18, 2026 |
| Feb 18, 2026 | Timothy Edward Lee Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -20,964 | $1.58 | $33k | 117,717 | Feb 18, 2026 |
| Feb 15, 2026 | William E. Duke Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -99,000 | $0.00 | $0 | 102,000 | Feb 18, 2026 |
| Feb 15, 2026 | Robert D. Allen III Chief Scientific Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -99,000 | $0.00 | $0 | 102,000 | Feb 18, 2026 |
| Feb 15, 2026 | Julie Green Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -99,000 | $0.00 | $0 | 102,000 | Feb 18, 2026 |
| Feb 15, 2026 | Timothy Edward Lee Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -99,000 | $0.00 | $0 | 102,000 | Feb 18, 2026 |
| Feb 15, 2026 | Jill Andersen Chief Legal Officer, Secretary | MOption exercise Restricted Stock Unitsderivative10b5-1 | -165,000 | $0.00 | $0 | 170,000 | Feb 18, 2026 |
| Jan 29, 2026 | Julie Green Chief Human Resources Officer | AGrant or award Stock Option (Right to Buy)derivative | +675,000 | $0.00 | $0 | 675,000 | Jan 30, 2026 |
| Jan 29, 2026 | Timothy Edward Lee Chief Commercial Officer | AGrant or award Stock Option (Right to Buy)derivative | +675,000 | $0.00 | $0 | 675,000 | Jan 30, 2026 |
| Jan 29, 2026 | Robert D. Allen III Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +625,000 | $0.00 | $0 | 625,000 | Jan 30, 2026 |
| Jan 29, 2026 | Jill Andersen Chief Legal Officer, Secretary | AGrant or award Stock Option (Right to Buy)derivative | +820,000 | $0.00 | $0 | 820,000 | Jan 30, 2026 |
| Jan 29, 2026 | William E. Duke Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +625,000 | $0.00 | $0 | 625,000 | Jan 30, 2026 |
| Nov 19, 2025 | Kevin F McLaughlin director | POpen-market purchase Common Stock | +50,000 | $2.50 | $125k | 50,000 | Nov 20, 2025 |
| Sep 22, 2025 | Paul Bolno director | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Sep 24, 2025 |
| Aug 15, 2025 | Robert D. Allen III Chief Scientific Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 99,000 | Aug 19, 2025 |
| Aug 15, 2025 | Timothy Edward Lee Chief Commercial Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 109,000 | Aug 19, 2025 |
| Aug 15, 2025 | Julie Green Chief Human Resources Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 99,000 | Aug 19, 2025 |
| Aug 15, 2025 | Jill Andersen Chief Legal Officer, Secretary | MOption exercise Common Stock10b5-1 | +165,000 | - | - | 167,200 | Aug 19, 2025 |
| Aug 15, 2025 | William E. Duke Chief Financial Officer | MOption exercise Common Stock10b5-1 | +99,000 | - | - | 99,000 | Aug 19, 2025 |
| Aug 18, 2025 | Robert D. Allen III Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -18,512 | $0.65 | $12k | 80,488 | Aug 19, 2025 |
| Aug 18, 2025 | Jill Andersen Chief Legal Officer, Secretary | SOpen-market sale Common Stock10b5-1 | -33,352 | $0.65 | $22k | 133,848 | Aug 19, 2025 |
| Aug 18, 2025 | William E. Duke Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -20,013 | $0.65 | $13k | 78,987 | Aug 19, 2025 |
| Aug 18, 2025 | Julie Green Chief Human Resources Officer | SOpen-market sale Common Stock10b5-1 | -20,013 | $0.65 | $13k | 78,987 | Aug 19, 2025 |
| Aug 18, 2025 | Timothy Edward Lee Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -20,013 | $0.65 | $13k | 88,987 | Aug 19, 2025 |
| Aug 19, 2025 | Robert D. Allen III Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -27,420 | $0.57 | $16k | 53,068 | Aug 19, 2025 |
| Aug 19, 2025 | Jill Andersen Chief Legal Officer, Secretary | SOpen-market sale Common Stock10b5-1 | -49,402 | $0.57 | $28k | 84,446 | Aug 19, 2025 |
| Aug 19, 2025 | William E. Duke Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -29,643 | $0.57 | $17k | 49,344 | Aug 19, 2025 |
| Aug 19, 2025 | Julie Green Chief Human Resources Officer | SOpen-market sale Common Stock10b5-1 | -29,643 | $0.57 | $17k | 49,344 | Aug 19, 2025 |
| Aug 19, 2025 | Timothy Edward Lee Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -29,643 | $0.57 | $17k | 59,344 | Aug 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Robert D. Allen IIIChief Scientific Officer
- Jill AndersenChief Legal Officer, Secretary
- Paul Bolnoceo, president, officer, director
- Tamsin Berrydirector
- William E. DukeChief Financial Officer
- Marc EliaChief Executive Officer
- Julie GreenChief Human Resources Officer
- Timothy Edward LeeChief Commercial Officer
- Terrance McGuiredirector
- Kevin F McLaughlindirector
- Ajay Royandirector, owner
- Ian Sheffielddirector
Questions about IVVD
Answered from the filings on this page, as of the latest one.
Are insiders buying IVVD?
No. In the last 90 days no insider at Invivyd, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade IVVD on the open market?
Robert D. Allen III (Chief Scientific Officer) sold $59k of IVVD on Feb 17, 2026 and filed the Form 4 on Feb 18, 2026. InsiderTell scored 7 (weak), under a 10b5-1 plan, with 5 insiders on the same side within 14 days.
How many insiders file Form 4 at Invivyd, Inc.?
12 people have filed a Form 4 at Invivyd, Inc., among them Robert D. Allen III (Chief Scientific Officer), Jill Andersen (Chief Legal Officer, Secretary), Paul Bolno (CEO, president and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.